Insmed Incorporated

NasdaqGS:INSM

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 20.81 B

Share Price

USD 109.55

Avg Daily Volume

3,670,888

Change (1 day)

0.23%

Change (1 year)

52.55%

Change (YTD)

58.68%

Insmed Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -237.91%

Insmed Incorporated EBIT Margin is -237.91% for the Trailing 12 Months (TTM) ending June 30, 2025, a 8.80% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Insmed Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -218.67%, a -7.76% change year over year.
Insmed Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -237.08%, a 32.21% change year over year.
Insmed Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -179.32%, a -11.47% change year over year.
Insmed Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -202.54%, a 56.21% change year over year.